
Stimvia graduates from NYU Stern’s elite accelerator, targets U.S. market with bladder therapy device
Stimvia, a MedTech company from the Czech Republic developing the URIS system, a non-invasive neuromodulation device for the treatment of overactive bladder (OAB), has graduated from the selective Endless Frontier Labs (EFL) program at NYU Stern School of …